1. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma – an Immunohistochemical Analysis
   Lizbeth Raju K et al, 2020, Pathology & Oncology Research CrossRef
2. The deregulated physiology in oral squamous cell carcinoma- a brief review
   Keerthika Saravanan et al, 2024, Oral Oncology Reports CrossRef
3. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis
   Ke Yang et al, 2019, International Journal of Clinical Oncology CrossRef
4. Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications
   Paolo Boscolo-Rizzo et al, 2016, Cancer and Metastasis Reviews CrossRef
5. Exploring the Dynamics of Propeller Loops in Human Telomeric DNA Quadruplexes Using Atomistic Simulations
   Barira Islam et al, 2017, Journal of Chemical Theory and Computation CrossRef
6. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors
   Ioanna Akrida et al, 2023, Medical Oncology CrossRef
7. TGF‐β‐mediated regulation of plasminogen activators is human telomerase reverse transcriptase dependent in cancer cells
   Rishi K. Jaiswal et al, 2019, BioFactors CrossRef
8. Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ ERK signaling pathways
   Tengda Zhao et al, 2015, Oncotarget CrossRef
9. Biomarkers in Oral Submucous Fibrosis
   Kannan Ranganathan et al, 2023, Oral Submucous Fibrosis CrossRef
10. Telomerase reverse transcriptase mutations are independent predictor of disease‐free survival in Middle Eastern papillary thyroid cancer
    Rong Bu et al, 2018, International Journal of Cancer CrossRef
11. Oral cancer: Deregulated molecular events and their use as biomarkers
    Nicoleta Sinevici et al, 2016, Oral Oncology CrossRef
12. Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors
    A. Prasanth Saraswati et al, 2019, Drug Discovery Today CrossRef
13. Alveolar epithelial-to-mesenchymal transition in scleroderma interstitial lung disease: Technical challenges, available evidence and therapeutic perspectives
    Enrico De Lorenzis et al, 2024, Journal of Scleroderma and Related Disorders CrossRef
14. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma
    Tomonori Sasahira et al, 2018, International Journal of Molecular Sciences CrossRef
15. Retracted: Exosomal miR‐1255b‐5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial‐to‐mesenchymal transition
    Xue Zhang et al, 2020, Molecular Oncology CrossRef
16. Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor‑related apoptosis‑inducing ligand‑induced oral squamous cell carcinoma apoptosis and suppresses proliferation in�vitro and in�vivo
    Xin Zhao et al, 2018, International Journal of Molecular Medicine CrossRef
17. Prognostic and Clinicopathological Significance of Telomerase Reverse Transcriptase Upregulation in Oral Cancer: A Systematic Review and Meta-Analysis
    Miguel Ángel González-Moles et al, 2022, Cancers CrossRef
18. Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant
    Elisa Majounie et al, 2020, Molecular Case Studies CrossRef
19. hTERT promotes tumor progression by enhancing TSPAN13 expression in osteosarcoma cells
    Rishi K. Jaiswal et al, 2018, Molecular Carcinogenesis CrossRef
20. Hallmarks of Cancer Expression in Oral Lichen Planus: A Scoping Review of Systematic Reviews and Meta-Analyses
    Miguel Ángel González-Moles et al, 2022, International Journal of Molecular Sciences CrossRef
21. Short-Term TERT Inhibition Impairs Cellular Proliferation via a Telomere Length-Independent Mechanism and Can Be Exploited as a Potential Anticancer Approach
    Aamir Amin et al, 2023, Cancers CrossRef
22. Functional and mechanistic analysis of telomerase: An antitumor drug target
    Yinnan Chen et al, 2016, Pharmacology & Therapeutics CrossRef